News
OTIC
0.3091
+34.98%
0.0801
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 2h ago
Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket
Benzinga · 2h ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 17h ago
What Is Going on With Asia Broadband (AABB) Stock Today?
Investor Place · 21h ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 21h ago
Why Is Otonomy (OTIC) Stock Up 97% Today?
Investor Place · 21h ago
Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 22h ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 1d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 6d ago
BRIEF-Otonomy Inc Says On Nov 14, 2022, Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Reuters · 11/18 22:03
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Benzinga · 11/18 10:14
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 11/17 17:32
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Benzinga · 11/16 10:01
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 11/11 13:26
Otonomy GAAP EPS of -$0.18
Seekingalpha · 11/10 22:05
Otonomy Q3 EPS $(0.18) Up From $(0.19) YoY
Benzinga · 11/10 21:57
Why Etsy Shares Are Trading Sharply Higher; Here Are 31 Stocks Moving Premarket
Benzinga · 11/03 11:50
Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday
Gainers Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update.
Benzinga · 10/14 08:53
Dow Surges 950 Points; S&P 500 Rises 3%
U.S. stocks traded higher toward the end of trading, with the Dow Jones jumping around 950 points on Thursday.
Benzinga · 10/13 19:13
More
Webull provides a variety of real-time OTIC stock news. You can receive the latest news about Otonomy Inc through multiple platforms. This information may help you make smarter investment decisions.
About OTIC
Otonomy, Inc. is a biopharmaceutical company. The Company is focused on the development of therapeutics for neurotology. The Company pipeline includes OTIPRIO, OTIVIDEX, OTO-313, and OTO-413. OTIPRIO is a single-dose, physician-administered antibacterial for the treatment of pediatric patients with bilateral otitis media with effusion undergoing TTP surgery for the treatment of patients with acute otitis externa (AOE). OTIVIDEX is a sustained-exposure formulation of the steroid dexamethasone in development for the treatment of Menieres disease. OTO-313 is a sustained-exposure formulation of gacyclidine, a potent and selective N-Methyl-D-Aspartate (NMDA) receptor antagonist, in in Phase II for tinnitus. OTO-413 is a sustained-exposure formulation of brain-derived neurotrophic factor (BDNF) in Phase IIa development for the repair of cochlear synaptopathy, an underlying pathology in age-related and noise-induced hearing loss. OTO-825, a gene therapy for congenital hearing loss.